Importance of early allergen contact for the development of a sustained immunoglobulin E response in a dog model.
BACKGROUND
Immunoglobulin E (IgE)-mediated allergies are postulated to require early allergen contact and sensitization for the full development of sustained IgE levels.


METHODS
Thirty-two Beagle dogs from seven litters selectively bred for their high IgE response were sensitized by subcutaneous injection of chicken ovalbumin (OVA), peanut extract and recombinant birch pollen allergen (Bet v 1). In half of the dogs from each litter, sensitization injections were started on the first day of life; the other half of the same litter was first sensitized at the age of 4 months. To evaluate whether early sensitization also predisposes the animals to IgE responses to other allergens later in life, we injected a recombinant timothy grass pollen allergen (Phl p 5) later on, at the age of 10-12 months. Allergen-specific serum IgE and IgG levels were evaluated with enzyme-linked immunosorbent assays. In addition, 21 dogs were challenged with aerosolized OVA to measure bronchoconstrictive changes in lung function.


RESULTS
Early sensitized dogs developed significantly higher OVA-specific serum IgE levels than late sensitized dogs, in contrast to the IgG levels, which were lower in these dogs (p < 0.001). The increase in specific serum IgE and IgG following boosting remained different between the two groups for over a year. Titers of specific serum IgE and IgG were also different after sensitization with a new allergen injected later in life for the first time. Dynamic pulmonary compliance and resistance, both parameters for bronchoconstriction induced by OVA aerosol challenge, were also significantly higher in early sensitized dogs (for both parameters, p < 0.01).


CONCLUSIONS
Contact with an allergen early in life is decisive for the development of sustained IgE levels and the development of IgE responses to additional allergens encountered later in life. Allergen avoidance during early life may have some preventive effect on IgE-mediated allergy in dogs.
Schiessl
B
B
Novartis Research Institute, Vienna, Austria.
Zemann
B
B
Hodgin-Pickart
L A
LA
de Weck
A L
AL
Griot-Wenk
M
M
Mayer
P
P
Nefzger
M
M
Schneider
H
H
Liehl
E
E
D000367:Age Factors; D000485:Allergens / Q000276:immunology*; D000818:Animals; D000831:Animals, Newborn; D052179:Antigens, Plant; D010367:Arachis / Q000276:immunology*; D004195:Disease Models, Animal; D004285:Dogs; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000096:biosynthesis / Q000097:blood / Q000276:immunology*; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D008297:Male; D010047:Ovalbumin / Q000276:immunology*; D010940:Plant Proteins / Q000276:immunology*; D012129:Respiratory Function Tests
D000485:Allergens; D052179:Antigens, Plant; D007074:Immunoglobulin G; C076049:Phl p V protein, Phleum pratense; D010940:Plant Proteins; C061312:Bet v 1 allergen, Betula; D007073:Immunoglobulin E; D010047:Ovalbumin